Here are the latest new cancer drugs approved by the Food and Drug Administration:

  • Abecma (idecabtagene vicleucel) CAR-T therapy for multiple myeloma
  • Fotivda (tivozanib) for advanced kidney cancer
  • Jemperli (dostarlimab) for endometrial cancer
  • Pepaxto (melphalan flufenamide) for multiple myeloma
  • Zynlonta (loncastuximab tesirine) for large B-cell lymphoma